Patents by Inventor Gerald Frangin

Gerald Frangin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120244106
    Abstract: This invention is related to the use of the combination of teriflunomide or a pharmaceutically acceptable salt thereof and glatiramer acetate for treating multiple sclerosis.
    Type: Application
    Filed: April 20, 2012
    Publication date: September 27, 2012
    Applicant: SANOFI-AVENTIS U.S. LLC
    Inventors: William BYRNES, Patrice DOUILLET, Gerald FRANGIN
  • Publication number: 20120107277
    Abstract: This invention is related to the use of the combination of teriflunomide and interferon beta thereof, for the preparation of a medicament for use in treating multiple sclerosis.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 3, 2012
    Applicant: SANOFI-AVENTIS U.S LLC
    Inventors: William BYRNES, Patrice DOUILLET, Gerald FRANGIN
  • Patent number: 5985915
    Abstract: The subject of the invention is a method for reducing mortality of cardiac origin in patients having a reduced left ventricular function after myocardial infarction, without rhythm disorders requiring an antiarrhythmic treatment, consisting in administering to said patients an effective amount of one or more active ingredients selected from benzofuran derivatives with antiarrhythmic activity and pharmaceutically acceptable salts thereof in combination with one or more pharmaceutically acceptable vehicles.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: November 16, 1999
    Assignee: Sanofi
    Inventors: Gerald Frangin, Alain Munoz